CPT vs KTTAW
Camden Property Trust (CPT) versus Pasithea Therapeutics Corp. Warrant (KTTAW) — a side-by-side from cached financials, not a winner call.
Camden Property Trust (CPT) is a reit - residential company listed on US.
Pasithea Therapeutics Corp. Warrant (KTTAW) is a biotechnology company listed on US.
Latest reported CPT revenue for 2026-06-30 was $5.3M. Net income was $61.2M. CPT currently screens at market cap $12.11B and trailing P/E 104.0.
KTTAW does not have a complete income-statement cache yet.
CPT currently screens at market cap $12.11B and trailing P/E 104.0. KTTAW currently screens at market cap $0.
Not investment advice. Open the CPT and KTTAW stock pages for the full models.
Not investment advice.